Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
January 25, 2014
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface
Huameng Li, Hui Xiao, Li Lin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
August 4, 2025
Abnormal Nuclear Membranous Staining Pattern by MLH1 Immunohistochemistry in Endometrial Cancer: A Diagnostic Pitfall and Clone-dependent Artifact
Lisha Wang, David Jou, Ruchi Patel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 24, 2021
Prostatic metaplasia and pilar differentiation in gender-affirming mastectomy specimens
Charlotte F Kim, David Jou, Oren Ganor, et al.
American Journal of Clinical Pathology
|
October 3, 2020
Impact of a Modified HistoGel Method for Processing Endocervical Curettage Specimens on Diagnostic Yield
Maximiliano Ramia de Cap, David Jou, Yigu Chen, et al.
The Journal of Biological Chemistry
|
October 15, 2014
A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells
Hui Xiao, Hemant Kumar Bid, David Jou, et al.
Ecology
|
March 23, 2019
The bioelements, the elementome, and the biogeochemical niche
Josep Peñuelas, Marcos Fernández-Martínez, Philippe Ciais, et al.
The Journal of Sports Medicine and Physical Fitness
|
February 7, 2019
The influence of non-modifiable and modifiable factors on cardiac biomarkers after marathon running
Thomas G Martin, Rachel W Pata, David Jou, et al.
International Journal of Oncology
|
October 18, 2016
STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells
Li Lin, David Jou, Yina Wang, et al.
Plos One
|
October 12, 2012
XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells
Aiguo Liu, Yan Liu, Zhigang Jin, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
MicroRNA spatial profiling for assessing drug efficacy in <i>BRCA1</i> -related triple-negative breast tumors
Omar N Mohd, Lin Wang, Brian R Sardella, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
January 25, 2014
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface
Huameng Li, Hui Xiao, Li Lin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
August 4, 2025
Abnormal Nuclear Membranous Staining Pattern by MLH1 Immunohistochemistry in Endometrial Cancer: A Diagnostic Pitfall and Clone-dependent Artifact
Lisha Wang, David Jou, Ruchi Patel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 24, 2021
Prostatic metaplasia and pilar differentiation in gender-affirming mastectomy specimens
Charlotte F Kim, David Jou, Oren Ganor, et al.
American Journal of Clinical Pathology
|
October 3, 2020
Impact of a Modified HistoGel Method for Processing Endocervical Curettage Specimens on Diagnostic Yield
Maximiliano Ramia de Cap, David Jou, Yigu Chen, et al.
The Journal of Biological Chemistry
|
October 15, 2014
A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells
Hui Xiao, Hemant Kumar Bid, David Jou, et al.
Ecology
|
March 23, 2019
The bioelements, the elementome, and the biogeochemical niche
Josep Peñuelas, Marcos Fernández-Martínez, Philippe Ciais, et al.
The Journal of Sports Medicine and Physical Fitness
|
February 7, 2019
The influence of non-modifiable and modifiable factors on cardiac biomarkers after marathon running
Thomas G Martin, Rachel W Pata, David Jou, et al.
International Journal of Oncology
|
October 18, 2016
STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells
Li Lin, David Jou, Yina Wang, et al.
Plos One
|
October 12, 2012
XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells
Aiguo Liu, Yan Liu, Zhigang Jin, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
MicroRNA spatial profiling for assessing drug efficacy in <i>BRCA1</i> -related triple-negative breast tumors
Omar N Mohd, Lin Wang, Brian R Sardella, et al.
Page
of 3